FIELD: pharmaceuticals.
SUBSTANCE: invention relates to a tablet-carrier for oral delivery, wherein the carrier tablet for delivery is formed by pressing a plurality of particles, wherein the oral tablet contains sugar alcohol (alcohols) in amount of 40 to 99.9 % by weight of the carrier tablet for delivery, wherein the oral tablet comprises particles not subject to direct pressing (non-DC) erythrite in amount of 15–50 % by weight of the carrier tablet for delivery, one or more binding substances, other than binding substances granulated with sugar alcohol (alcohols), in amount of 0.1 to 6 % by weight of the tablet, plurality of sugar alcohol additional particles in amount of at least 10 % by weight of carrier tablet for delivery, and wherein said additional particles of sugar alcohols differ from said non-DC erythrite.
EFFECT: disclosed is a tablet containing a separate binding substance and erythrite.
18 cl, 5 tbl, 20 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CARRIER FOR ORAL DELIVERY | 2016 |
|
RU2738205C1 |
| TABLET FOR ORAL ADMINISTRATION FOR INDUCED SALIVA FORMATION | 2019 |
|
RU2782830C2 |
| ION EXCHANGE COMPOSITION WITH WATER-SOLUBLE MUCOADHESIVE POLYMERS | 2020 |
|
RU2812603C1 |
| CHEWING GUM IN TABLET FORM, SUITABLE FOR ACTIVE PHARMACEUTICAL INGREDIENTS | 2019 |
|
RU2770035C1 |
| SOLID ORAL NICOTINE COMPOSITION | 2018 |
|
RU2786451C2 |
| PRESSED NICOTINE LOZENGE | 2020 |
|
RU2825844C1 |
| METHOD FOR PROVISION OF THERAPEUTIC AND PREVENTIVE EFFECTS OF ORAL CARE | 2017 |
|
RU2783120C2 |
| NICOTINE COMPOSITION FOR PERORAL APPLICATION, WHICH CONTAINS AMINO-ACID BUFFER | 2008 |
|
RU2465904C2 |
| QUICKLY DECOMPOSING, PRESSED IN FORMS MATERIALS AND METHOD OF THEIR PREPARING | 1997 |
|
RU2189227C2 |
| SOLID NICOTINE-CONTAINING DOSAGE FORM WITH REDUCED UNPLEASANT ORGANOLEPTIC IMPACT | 2013 |
|
RU2623018C2 |
